Søgeresultater - David J. Inwards
- Showing 1 - 20 results of 76
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders af Andrew P. Sciallis, Mark E. Law, David J. Inwards, Rebecca F. McClure, William R. Macon, Paul J. Kurtin, Ahmet Doǧan, Andrew L. Feldman
Udgivet 2012Artigo -
13
Awareness and utilization of pre-exposure prophylaxis and HIV prevention services among transgender and non-binary adolescent and young adults af Arianna Rodriguez, Keith J. Horvath, Nadia Dowshen, Raina V. Voss, Jonathan Warus, Megan A Jacobs, Kacie M. Kidd, David J. Inwards-Breland, Jill Blumenthal
Udgivet 2024Artigo -
14
Early Lymphocyte Recovery Predicts Superior Survival after Autologous Stem Cell Transplantation in Non-Hodgkin Lymphoma: A Prospective Study af Luis F. Porrata, David J. Inwards, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, Dennis A. Gastineau, Mark R. Litzow, Jeffrey L. Winters, Svetomir N. Markovic
Udgivet 2008Artigo -
15
Testicular lymphoma is associated with a high incidence of extranodal recurrence af Rafaël Fonseca, Thomas M. Habermann, Joseph P. Colgan, Brian Patrick O’Neill, William L. White, Thomas E. Witzig, Kathleen S. Egan, James A. Martenson, Lawrence J. Burgart, David J. Inwards
Udgivet 2000Artigo -
16
Long‐term results of the treatment of patients with mantle cell lymphoma with cladribine (2‐CDA) alone (95‐80‐53) or 2‐CDA and rituximab (N0189) in the North Central Cancer Treatme... af David J. Inwards, Paul A. S. Fishkin, David W. Hillman, David W. Brown, Stephen M. Ansell, Paul J. Kurtin, Rafaël Fonseca, Roscoe F. Morton, Michael H. Veeder, Thomas E. Witzig
Udgivet 2008Artigo -
17
Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate af MA Gertz, Martha Q. Lacy, Angela Dispenzieri, Stephen M. Ansell, M. A. Elliott, D A Gastineau, David J. Inwards, Ivana N. Micallef, Luis F. Porrata, Ayalew Tefferi, Mark R. Litzow
Udgivet 2004Artigo -
18
Everolimus combined with R-CHOP-21 for new, untreated, diffuse large B-cell lymphoma (NCCTG 1085 [Alliance]): safety and efficacy results of a phase 1 and feasibility trial af Patrick B. Johnston, Betsy LaPlant, Ellen D. McPhail, Thomas M. Habermann, David J. Inwards, Ivana N. Micallef, Joseph P. Colgan, Grzegorz S. Nowakowski, Stephen M. Ansell, Thomas E. Witzig
Udgivet 2016Artigo -
19
Quality of life at diagnosis predicts overall survival in patients with aggressive lymphoma af Carrie A. Thompson, Kathleen J. Yost, Matthew J. Maurer, Cristine Allmer, Umar Farooq, Thomas M. Habermann, David J. Inwards, William R. Macon, Brian K. Link, Allison Rosenthal, James R. Cerhan
Udgivet 2018Artigo -
20
Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study af Stephen M. Ansell, Hui Tang, Paul J. Kurtin, Patricia Koenig, David J. Inwards, Keith Shah, Steven C. Ziesmer, Andrew L. Feldman, Radha M. Rao, Mamta Gupta, Charles Erlichman, Thomas E. Witzig
Udgivet 2011Artigo
Søgeredskaber:
Relaterede emner
Medicine
Internal medicine
Lymphoma
Oncology
Gastroenterology
Transplantation
Surgery
Immunology
Chemotherapy
Biology
Hematopoietic stem cell transplantation
Rituximab
Confidence interval
Genetics
Diffuse large B-cell lymphoma
Physics
Stem cell
Antibody
Cancer
Follicular lymphoma
Autologous stem-cell transplantation
Hazard ratio
Multiple myeloma
Psychology
Cohort
Environmental health
Haematopoiesis
Lymphocyte
Mantle cell lymphoma
Progression-free survival